GlycoMimetics Inc (GLYC)

3.28 -0.07  -2.09% NASDAQ Oct 19, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
11/06/2020 08:30 EST Misc GlycoMimetics Inc Third Quarter Earnings Conference Call for 2020
11/06/2020 Earnings GlycoMimetics Inc Third Quarter Earnings for 2020 Release
07/31/2020 08:30 EDT Misc GlycoMimetics Inc Second Quarter Earnings Conference Call for 2020
07/31/2020 Earnings GlycoMimetics Inc Second Quarter Earnings Result for 2020
05/22/2020 Misc GlycoMimetics Inc Annual General Meeting for 2019
05/01/2020 08:30 EDT Misc GlycoMimetics Inc First Quarter Earnings Conference Call for 2020
05/01/2020 Earnings GlycoMimetics Inc First Quarter Earnings Result for 2020
02/28/2020 08:30 EST Misc GlycoMimetics Inc Fourth Quarter Earnings Conference Call for 2019
02/28/2020 Earnings GlycoMimetics Inc Fourth Quarter Earnings for 2019 Release
02/28/2020 Misc GlycoMimetics Inc Annual Report for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.glycomimetics.com
  • Investor Relations URL: http://ir.glycomimetics.com/
  • HQ State/Province: Maryland
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 06, 2020
  • Last Earnings Release: Jul. 31, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.

Top Fund Holders

Symbol Name Weighting
BRSGX Bridgeway Small-Cap Growth 1.66%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.